fresno semaglutide A new, more affordable weight loss medication in the form of a pill is now available on the market. 💊 Endocrinologist Dr. Mandeep Gill, Assistant Professor at UCSF Fresno, contributed her insights Valley doctors discuss recent trend

16 , eadp5765 (2024)

To assess the associations of semaglutide with incident CUD (first time diagnosis of CUD), the study population included 83,189 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications (bupropion, naltrexone, orlistat, topiramate, phentermine) [39] during 6/2021-12/2022 (time zero or index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event

Always mark the puncture date on the vial label

There is a nice sake selection included on this comprehensive list